We are happy to share that Nathalie Maubon, PhD, our CEO/CSO is currently attending BioAsia Taiwan, organized in Taipei. The event aims at building on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities Read more…
I will be pleased to be in BIO-Europe Spring in Basel, Switzerland to present BIOMIMESYS, our breakthrough technology and our new results that we have with it. In HCS Pharma, we are reinventing biology with our academic partners by analyzing the impact of changes in the microenvironment on cells and Read more…
We are glad to announce the arrival of Gaspard in our team! Gaspard Delpouve obtained his Diploma of Advanced Technician in Biotechnologies in Lille in 2018, and in 2019 he passed a Bachelor’s degree in health biotechnologies at the University of Nantes. During his studies he completed several internships in Read more…
Dear all, please feel free to contact Elodie who will be in RDV Carnot event in Paris (Espace Champerret, 17e arrondissement) tomorrow and on Thursday. Since HCS Pharma was selected as a laureate amongst innovative start-ups and SMEs for this ecent, she will be the first to pitch at 11:40 Read more…
Dans le cadre de notre développement, nous recrutons un(e) Technicien(ne) en recherche et développement axée sur des modèles hépatiques in vitro. Vous serez en charge de : Gestion du laboratoire (commandes, entretien des machines, règles HSE, gestion des stocks) Maintien des cultures cellulaires en routine (lignées, cellules primaires, cellules souches, etc…) Read more…
We are pleased and proud to welcome Dr Philippe Manivet and Dr Anthony Trezeibre in our Scientific Advisory Board. We are developing new innovative projects with them around our BIOMIMESYS technology. Because our BIOMIMESYS technology is requested in different fields and we want to stay at the forefront of innovation, Read more…
As you may now, in HCS Pharma we strongly believe that the critical point of the human health evolution in next years is the in vitro 3D cell culture, especially for complex diseases like cancer [1]. It’s why we work hard on our exclusive BIOMIMESYS® technology. As experts in HCS and cell imaging, we must master all the process : 3D biological models, 3D cell culture, volumetric pictures acquisition, 3D reconstruction and segmentation of cells and ECM compounds, 3D parameters extraction and, of course, biological interpretations. As explained in our VisuAI R&D project, the 3D reconstruction and segmentation step is not simple.
With more than 1100 researchers and exhibiting experts, “Rendez-vous Carnot” offers a complete ecosystem of R&D and innovation support. We will attend at two-day Rendez vous CARNOT (October 16-17 in Paris) to present our innovations on 3D cell culture with our unique and proprietary technology BIOMIMESYS®… Also we will present our activities Read more…
It is a great pleasure for us to welcome a new member in our scientific advisory board, Dr Samuel Meignan! He will for sure help us to develop relevant models related to oncology therapeutic area. Dr. Samuel Meignan is a senior researcher at the Inserm U908 laboratory ‘Cell Plasticity and Read more…
HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, George Haase, Karim Si Tayed… and a new board member: Dominique Collard! Dominique is known Read more…
We are happy to announce that Brittany region continue to help us (article in french) and co-funds one of our R&D projects in collaboration with Dr Anne Corlu, head of team 2 and Dr Bernard Fromenty, head of team 3 of UMR991 directed by Dr Bruno Clément in Rennes.
We will be attending BioFIT on 1st and 2nd of December 2015, placed in Strasbourg. BioFIT is one of the best european place to be for B to B meetings